News and Events Recent News Oct 8, 2020 Takeda and Arrowhead Collaborate to Co-Develop and Co-Commercialize ARO-AAT for Alpha-1 Antitrypsin-Associated Liver Disease Sep 30, 2020 Arrowhead Pharmaceuticals to Participate in Upcoming Investor Conference Sep 24, 2020 Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) View More » Recent Events Oct 8, 2020 Arrowhead/Takeda Collaboration Call Oct 6, 2020 Chardan Virtual 4th Annual Genetic Medicines Conference Sep 15, 2020 Cantor Fitzgerald Global Healthcare Conference 2020 View More »
Oct 8, 2020 Takeda and Arrowhead Collaborate to Co-Develop and Co-Commercialize ARO-AAT for Alpha-1 Antitrypsin-Associated Liver Disease
Sep 24, 2020 Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)